Family planning is the second most relevant factor for treatment decisions after disease activity - Commentary.
dc.contributor.author | Jokubaitis, VG | en_US |
dc.contributor.author | Dobson, R | en_US |
dc.date.accessioned | 2020-03-03T13:59:44Z | |
dc.date.available | 2020-01-24 | en_US |
dc.date.issued | 2020-02-21 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/63008 | |
dc.format.extent | 1352458520907902 - ? | en_US |
dc.language | eng | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Mult Scler | en_US |
dc.title | Family planning is the second most relevant factor for treatment decisions after disease activity - Commentary. | en_US |
dc.title.alternative | Family planning is the second most relevant factor for treatment decisions after disease activity | en_US |
dc.type | Article | |
dc.rights.holder | © The Author(s) 2020. | |
dc.identifier.doi | 10.1177/1352458520907902 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/32081081 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published online | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |